These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15024137)
21. Use of the QuantiFERON TB Gold test as part of a screening programme in patients with RA under consideration for treatment with anti-TNF-alpha agents: the Newcastle (UK) experience. Pratt A; Nicholl K; Kay L Rheumatology (Oxford); 2007 Jun; 46(6):1035-6. PubMed ID: 17409126 [No Abstract] [Full Text] [Related]
22. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Kapetanovic MC; Saxne T; Nilsson JA; Geborek P Rheumatology (Oxford); 2007 Apr; 46(4):608-11. PubMed ID: 17114801 [TBL] [Abstract][Full Text] [Related]
23. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133 [TBL] [Abstract][Full Text] [Related]
24. Infection and musculoskeletal conditions: Bacterial and opportunistic infections during anti-TNF therapy. Strangfeld A; Listing J Best Pract Res Clin Rheumatol; 2006 Dec; 20(6):1181-95. PubMed ID: 17127203 [TBL] [Abstract][Full Text] [Related]
25. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results. Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981 [TBL] [Abstract][Full Text] [Related]
26. [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations]. Faucherre M; Pazar B; So A; Aubry-Rozier B Rev Med Suisse; 2011 Jan; 7(277):75-6, 78-9. PubMed ID: 21309182 [TBL] [Abstract][Full Text] [Related]
27. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Wolfe F; Michaud K Arthritis Rheum; 2004 Jun; 50(6):1740-51. PubMed ID: 15188349 [TBL] [Abstract][Full Text] [Related]
28. Infectious complications of biologic agents. Martin-Mola E; Balsa A Rheum Dis Clin North Am; 2009 Feb; 35(1):183-99. PubMed ID: 19481004 [TBL] [Abstract][Full Text] [Related]
29. Anti-tumor necrosis factor alpha therapy and the risk of lymphoma in rheumatoid arthritis: no clear answer. Symmons DP; Silman AJ Arthritis Rheum; 2004 Jun; 50(6):1703-6. PubMed ID: 15188344 [No Abstract] [Full Text] [Related]
30. Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. Ferri C; Ferraccioli G; Ferrari D; Galeazzi M; Lapadula G; Montecucco C; Triolo G; Valentini G; Valesini G; J Rheumatol; 2008 Oct; 35(10):1944-9. PubMed ID: 18688917 [TBL] [Abstract][Full Text] [Related]
33. Emerging biologic drugs for the treatment of rheumatoid arthritis. Puppo F; Murdaca G; Ghio M; Indiveri F Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092 [TBL] [Abstract][Full Text] [Related]
34. Do antitumor necrosis factor agents increase the risk of postoperative orthopedic infections? Pappas DA; Giles JT Curr Opin Rheumatol; 2008 Jul; 20(4):450-6. PubMed ID: 18525360 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933 [TBL] [Abstract][Full Text] [Related]
36. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis. Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278 [No Abstract] [Full Text] [Related]
37. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Wendling D; Balblanc JC; Brousse A; Lohse A; Lehuede G; Garbuio P; Toussirot E; Auge B; Jacques D Ann Rheum Dis; 2005 Sep; 64(9):1378-9. PubMed ID: 16100348 [No Abstract] [Full Text] [Related]
38. Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort study. Lee SJ; Chang H; Yazici Y; Greenberg JD; Kremer JM; Kavanaugh A J Rheumatol; 2009 Aug; 36(8):1611-7. PubMed ID: 19369454 [TBL] [Abstract][Full Text] [Related]
39. Pericardial effusions on anti-TNF therapy for rheumatoid arthritis--a drug side effect or uncontrolled systemic disease? Edwards MH; Leak AM Rheumatology (Oxford); 2009 Mar; 48(3):316-7. PubMed ID: 19106166 [No Abstract] [Full Text] [Related]
40. Anti-TNFalpha therapy and vaccination of adults. Duchet-Niedziolka P; Coutsinos Z; Hanslik T; Launay O Joint Bone Spine; 2007 Dec; 74(6):563-5. PubMed ID: 18023395 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]